Journal of Medicinal Chemistry p. 1003 - 1020 (2016)
Update date:2022-08-15
Topics:
Demont, Emmanuel H.
Bailey, James M.
Bit, Rino A.
Brown, Jack A.
Campbell, Colin A.
Deeks, Nigel
Dowell, Simon J.
Eldred, Colin
Gaskin, Pam
Gray, James R. J.
Haynes, Andrea
Hirst, David J.
Holmes, Duncan S.
Kumar, Umesh
Morse, Mary A.
Osborne, Greg J.
Renaux, Jessica F.
Seal, Gail A. L.
Smethurst, Chris A.
Taylor, Simon
Watson, Robert
Willis, Robert
Witherington, Jason
FTY720 is the first oral small molecule approved for the treatment of people suffering from relapsing-remitting multiple sclerosis. It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor ha
View Morewebsite:http://www.hanwayschem.com
Contact:+86-18502787239(whatsapp)
Address:18-1-802, Green Garden, Jianghan District, Wuhan 430023, China
Contact:18698110882
Address:1303 No2 building,LuoMa Garden,YongAn Road,Hexi District,Tianjin city
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Beijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
Doi:10.1016/j.tetlet.2010.09.062
(2010)Doi:10.1021/ma102386j
(2011)Doi:10.1039/c0cc03004j
(2010)Doi:10.1016/S0040-4039(00)99258-X
(1989)Doi:10.1016/j.bmcl.2010.09.138
(2010)Doi:10.1007/s10593-014-1425-3
(2014)